The Government has issued Decree 90/2026 on administrative sanctions in the healthcare sector, effective May 15. The new regulations significantly... Read more
Category: Uncategorized
Vietnam and India boost cooperation in pharmaceutical management
During the state visit to India by the high-level Vietnamese delegation led by General Secretary and President To Lam, the... Read more
Roche to acquire PathAI for over $1 billion to transform AI-driven diagnostics
Roche has announced a definitive merger agreement to acquire PathAI, a leader in digital pathology and AI-powered technology. This acquisition... Read more
Bayer to acquire Perfuse for up to $2.45B to bolster its ophthalmology pipeline
Bayer has agreed to acquire San Francisco-based biotech startup Perfuse Therapeutics in a deal potentially worth $2.45 billion. This marks... Read more
Merck completes $5.8 billion acquisition of Terns Pharmaceuticals
Merck (known as MSD outside the U.S. and Canada) has announced the successful completion of its acquisition of Terns Pharmaceuticals.... Read more
Pfizer scuttles $2.3B Trillium investment and exits current T-cell engager modality
Pfizer has announced a major trimming of its clinical pipeline, marked by the total collapse of its $2.3 billion Trillium... Read more
Teva inks $900M Emalex buyout to expand Tourette syndrome pipeline
Teva Pharmaceuticals has proposed the acquisition of Emalex Biosciences, a move that integrates a promising pediatric Tourette syndrome therapy into... Read more
Sanofi invests $294M to scale its global AI hub in Toronto
French pharmaceutical giant Sanofi is investing $294 million to expand its global AI center of excellence in Toronto, Canada. This... Read more
Novartis to shutter German plant as part of shift toward advanced medical modalities
The Swiss pharmaceutical giant Novartis has announced plans to close its manufacturing facility in Wehr, Germany, by the end of... Read more









